Pine River Capital Management’s AbbVie ABBV Stock Holding History

Pine River Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-35,100	Closed	-$2.3M	–	600
2014 Q4	$2.3M	Sell	35,100 -253,400	-88%	-$16M	0.03%	382
2014 Q3	$16.7M	Buy	288,500 +267,500	+1,274%	+$14.9M	0.19%	107
2014 Q2	$1.19M	Sell	21,000 -131,600	-86%	-$6.9M	0.02%	501
2014 Q1	$7.84M	Sell	152,600 -26,400	-15%	-$1.33M	0.12%	212
2013 Q4	$9.45M	Sell	179,000 -25,300	-12%	-$1.24M	0.12%	213
2013 Q3	$9.14M	Buy	204,300 +65,200	+47%	+$2.89M	0.1%	193
2013 Q2	$5.75M	Buy	+139,100	New	+$6.08M	0.08%	219

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Pine River Capital Management's ABBV Position: Q1 2016 in Review

Pine River Capital Management sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 82,639 shares — an estimated $4.89M sold.

Pine River Capital Management first reported a position in ABBV in Q2 2014 and held it in 5 quarters. The position peaked at $21.5M in Q2 2015. 1,638 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Pine River Capital Management reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
Pine River Capital Management sold 82,639 AbbVie shares in Q1 2016, an estimated $4.89M.
Pine River Capital Management first reported a position in AbbVie in Q2 2014 and held it in 5 quarters.
Pine River Capital Management's AbbVie position peaked at $21.5M in Q2 2015.
1,638 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Pine River Capital Management's 13F filing for Q1 2016, filed 16 May 2016.